The independent Disciplinary Panel of the British Horseracing Authority (BHA) will convene today to consider whether or not John Gosden, a licensed trainer and the responsible person, is in breach of Rule (K)1 of the pre-September 2020 Rules of Racing due to the presence of Triamcinolone Acetonide in a pre-race sample taken from ROYAL LINE prior to The Qipco British Champions Long Distance Cup (Class 1) (Group 2) on 19 October 2019; and Whether, as its pre-race sample tested positive for a Prohibited Substance, ROYAL LINE should be disqualified from the relevant race under Rule (L)47 Ground 4.
The Panel for the Enquiry will be: Philip Curl (Chair), Steve Winfield and Rachel Spearing.
Triamcinolone acetonide (TCA) is a synthetic corticosteroid with anti-inflammatory and analgesic action. There are a number of licensed preparations containing TCA available for use in humans, but there are no licensed veterinary preparations of TCA. Human preparations of TCA can and regularly are prescribed for use in animals under the prescribing cascade as set out by the Veterinary Medicines Directorate. TCA may have a pharmacological effect on multiple mammalian body systems and is, therefore, a Prohibited Substance on raceday.
Due to the current situation and resulting difficulties arising from the corona virus, temporary changes have been made to how the Judicial Panel operates. Initial changes can be seen in a statement here issued on 1 April, with a further operational update issued on 1 June here.
